S100A11 and pancreatic intraductal papillary-mucinous neoplasm: Their research revealed overexpression of S100A11 in the early stages of pancreatic cancer development, such as in intraductal papillary mucinous neoplasms and pancreatic intraepithelial neoplasia (Ohuchida et al., 2006).